keyword
https://read.qxmd.com/read/38655053/linc01614-is-a-promising-diagnostic-and-prognostic-marker-in-hnsc-linked-to-the-tumor-microenvironment-and-oncogenic-function
#1
JOURNAL ARTICLE
Xiong Tian, Dali Hu, Na Wang, Lele Zhang, Xuequan Wang
BACKGROUND: Tumor initiation and metastasis influence tumor immune exclusion and immunosuppression. Long non-coding RNA (lncRNA) LINC01614 is associated with the prognosis and metastasis of several cancers. However, the relationship between LINC01614 and cancer immune infiltration and the biofunction of LINC01614 in head and neck squamous cell carcinoma (HNSC) remain unclear. METHODS: The Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) datasets were used to analyze the expression difference and diagnostic value of LINC01614 in normal and tumor tissues...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38639184/cetuximab-chemotherapy-resistance-insight-into-the-homeostatic-evolution-of-head-and-neck-cancer-review
#2
JOURNAL ARTICLE
Carlos Henrique De Paula Diniz, Tiago Henrique, Ana Carolina B Stefanini, Tialfi Bergamin De Castro, Eloiza H Tajara
The complex evolution of genetic alterations in cancer that occurs in vivo is a selective process involving numerous factors and mechanisms. Chemotherapeutic agents that prevent the growth and spread of cancer cells induce selective pressure, leading to rapid artificial selection of resistant subclones. This rapid evolution is possible because antineoplastic drugs promote alterations in tumor‑cell metabolism, thus creating a bottleneck event. The few resistant cells that survive in this new environment obtain differential reproductive success that enables them to pass down the newly selected resistant gene pool...
June 2024: Oncology Reports
https://read.qxmd.com/read/38630141/metastatic-cutaneous-squamous-cell-carcinoma-accounts-for-nearly-all-squamous-cell-carcinomas-of-the-parotid-gland
#3
REVIEW
Patrick J Bradley, Göran Stenman, Lester D R Thompson, Alena Skálová, Roderick H W Simpson, Pieter J Slootweg, Alessandro Franchi, Nina Zidar, Alfons Nadal, Henrik Hellquist, Michelle D Williams, Ilmo Leivo, Abbas Agaimy, Alfio Ferlito
Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that pSCCP is exceptionally rare. Yet, there are many publications describing series of pSCCP and data from SEER and other cancer register databases indicate erroneously an increasing incidence of pSCCP. Importantly, pSCCP and metastatic (secondary) squamous cell carcinoma to the parotid gland (mSCCP) have nearly identical histological features, and the diagnosis of pSCCP should only be made after the exclusion of mSCCP...
April 17, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38618458/comprehensive-analysis-reveals-deoxyribonuclease-1-as-a-potential-prognostic-and-diagnostic-biomarker-in-human-cancers
#4
JOURNAL ARTICLE
Loai F Eletr, Sahar H Ibnouf, Tanzeel A Salih, Hadba I Ibrahim, Mustafa I Mustafa, Nasma A Alhashmi, Mohamed Alfaki
BACKGROUND: Deoxyribonuclease 1 (DNASE1) is an important gene associated with several cancers, including liver, bladder, and gastric cancer. It has been linked to autoimmune illnesses, including systemic lupus erythematosus, which may lead to cancer formation. However, the role of DNASE1 in cancer has not been studied. MATERIALS AND METHODS: We performed a pan-cancer analysis using bioinformatics tools, including Tumor Immune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), and University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN) databases, Kaplan-Meier plotter, and cBioPortal, to investigate the expression of DNASE1 across various cancers as well as its association with immune infiltration and genetic alterations...
March 2024: Curēus
https://read.qxmd.com/read/38616205/estimating-the-prognostic-value-of-the-ntrk-fusion-biomarker-for-comparative-effectiveness-research-in-the-netherlands
#5
JOURNAL ARTICLE
Irene Santi, Heleen Vellekoop, Matthijs M Versteegh, Simone A Huygens, Winand N M Dinjens, Maureen Rutten-van Mölken
OBJECTIVES: We evaluated the prognostic value of the neurotrophic tyrosine receptor kinase (NTRK) gene fusions by comparing the survival of patients with NTRK+ tumours with patients without NTRK+ tumours. METHODS: We used genomic and clinical registry data from the Center for Personalized Cancer Treatment (CPCT-02) study containing a cohort of cancer patients who were treated in Dutch clinical practice between 2012 and 2020. We performed a propensity score matching analysis, where NTRK+ patients were matched to NTRK- patients in a 1:4 ratio...
April 14, 2024: Molecular Diagnosis & Therapy
https://read.qxmd.com/read/38615585/mutational-landscape-of-oral-mucosal-melanoma-based-on-comprehensive-cancer-genomic-profiling-tests-in-a-japanese-cohort
#6
JOURNAL ARTICLE
Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hibi
OBJECTIVES: Oral mucosal melanoma (OMM) is a rare but aggressive melanoma subtype. Due to its rarity, the genomic landscape of OMM remains unknown despite a relatively thorough understanding of the genetic profile of cutaneous melanoma (CM). In this study, we analyzed the genomic mutational profiles of Japanese patients with OMM and compared them with those of patients with nose/sinuses mucosal melanoma (NMM) and CM to identify potential therapeutic targets. MATERIALS AND METHODS: We extracted clinical and genomic information of patients with OMM (n = 15), NMM (n = 63), and CM (n = 413) who underwent comprehensive genomic profiling tests under the National Health Insurance between June 2019 and November 2023 from the Center for Cancer Genomics and Therapeutics database...
April 12, 2024: Oral Oncology
https://read.qxmd.com/read/38600608/polycomb-repressive-complex-2-and-its-core-component-ezh2-potential-targeted-therapeutic-strategies-for-head-and-neck-squamous-cell-carcinoma
#7
REVIEW
Yuxi Cheng, Zhengzheng Song, Xiaodan Fang, Zhangui Tang
The polycomb group (PcG) comprises a set of proteins that exert epigenetic regulatory effects and play crucial roles in diverse biological processes, ranging from pluripotency and development to carcinogenesis. Among these proteins, enhancer of zeste homolog 2 (EZH2) stands out as a catalytic component of polycomb repressive complex 2 (PRC2), which plays a role in regulating the expression of homologous (Hox) genes and initial stages of x chromosome inactivation. In numerous human cancers, including head and neck squamous cell carcinoma (HNSCC), EZH2 is frequently overexpressed or activated and has been identified as a negative prognostic factor...
April 10, 2024: Clinical Epigenetics
https://read.qxmd.com/read/38593239/proton-flash-radiotherapy-ameliorates-radiation-induced-salivary-gland-dysfunction-and-oral-mucositis-and-increases-survival-in-a-mouse-model-of-head-and-neck-cancer
#8
JOURNAL ARTICLE
Priyanka Chowdhury, Anastasia Velalopoulou, Ioannis I Verginadis, George Morcos, Phoebe E Loo, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Khayrullo Shoniyozov, Eric S Diffenderfer, Emilio A Ocampo, Mary Putt, Charles-Antoine Assenmacher, Enrico Radaelli, Jiawei Lu, Ling Qin, Hengxi Liu, Nektaria Maria Leli, Swati Girdhani, Nicolas Denef, Francois Vander Stappen, Keith A Cengel, Theresa M Busch, James M Metz, Lei Dong, Alexander Lin, Constantinos Koumenis
Head and neck cancer radiotherapy often damages salivary glands and oral mucosa, severely negatively impacting patients' quality of life. The ability of FLASH- Proton Radiation therapy (F-PRT) to decrease normal tissue toxicity while maintaining tumor control compared to Standard Proton Radiation therapy (S-PRT) has been previously demonstrated for several tissues. However, its potential in ameliorating radiation-induced salivary gland dysfunction and oral mucositis and controlling orthotopic head and neck tumor growth has not been reported...
April 9, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38590400/higher-overall-survival-rates-of-oral-squamous-cell-carcinoma-treated-with-metronomic-neoadjuvant-chemotherapy
#9
JOURNAL ARTICLE
Shinichiro Kina, Sho Miyamoto, Reika Kawabata-Iwakawa, Mika Kina-Tanada, Masaru Ogawa, Satoshi Yokoo
Distant metastasis is an important prognostic factor for oral squamous cell carcinoma (OSCC). It involves the direct spread of tumor cells through blood vessels or via lymph nodes; however, there are currently no well-established treatments for its prevention in patients with OSCC. To investigate the impact of metronomic neoadjuvant chemotherapy on OSCC, we conducted a retrospective analysis of the efficacy of neoadjuvant chemotherapy with S-1 alone. Fifty-four patients underwent up-front surgery, while 106 received neoadjuvant chemotherapy with S-1 alone...
2024: American Journal of Cancer Research
https://read.qxmd.com/read/38589501/integrative-analysis-reveals-associations-between-oral-microbiota-dysbiosis-and-host-genetic-and-epigenetic-aberrations-in-oral-cavity-squamous-cell-carcinoma
#10
JOURNAL ARTICLE
Liuyang Cai, Hengyan Zhu, Qianqian Mou, Po Yee Wong, Linlin Lan, Cherrie W K Ng, Pu Lei, Man Kit Cheung, Daijuanru Wang, Eddy W Y Wong, Eric H L Lau, Zenon W C Yeung, Ronald Lai, Katie Meehan, Sherwood Fung, Kwan Chee A Chan, Vivian W Y Lui, Alfred S L Cheng, Jun Yu, Paul K S Chan, Jason Y K Chan, Zigui Chen
Dysbiosis of the human oral microbiota has been reported to be associated with oral cavity squamous cell carcinoma (OSCC) while the host-microbiota interactions with respect to the potential impact of pathogenic bacteria on host genomic and epigenomic abnormalities remain poorly studied. In this study, the mucosal bacterial community, host genome-wide transcriptome and DNA CpG methylation were simultaneously profiled in tumors and their adjacent normal tissues of OSCC patients. Significant enrichment in the relative abundance of seven bacteria species (Fusobacterium nucleatum, Treponema medium, Peptostreptococcus stomatis, Gemella morbillorum, Catonella morbi, Peptoanaerobacter yurli and Peptococcus simiae) were observed in OSCC tumor microenvironment...
April 8, 2024: NPJ Biofilms and Microbiomes
https://read.qxmd.com/read/38576614/new-hopes-for-the-breast-cancer-treatment-perspectives-on-the-oncolytic-virus-therapy
#11
REVIEW
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, Martyna Borowczyk, Małgorzata Braszka, Grzegorz Dworacki, Paula Dobosz, Mateusz Wichtowski
Oncolytic virus (OV) therapy has emerged as a promising frontier in cancer treatment, especially for solid tumours. While immunotherapies like immune checkpoint inhibitors and CAR-T cells have demonstrated impressive results, their limitations in inducing complete tumour regression have spurred researchers to explore new approaches targeting tumours resistant to current immunotherapies. OVs, both natural and genetically engineered, selectively replicate within cancer cells, inducing their lysis while sparing normal tissues...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38575815/increased-sec14l2-expression-is-associated-with-clinicopathological-features-and-worse-prognosis-in-oral-squamous-cell-carcinoma
#12
JOURNAL ARTICLE
Jonah Justin David, Balachander Kannan, Chandra Pandi, Vijayashree Priyadharsini Jayaseelan, Jeevitha Manicka Vasagam, Paramasivam Arumugam
Abnormal expression of SEC14L2 has been implicated in many human cancers. However, the role of SEC14L2 in oral squamous cell carcinoma (OSCC) remains unclear. Therefore, this study aimed to evaluate the expression and prognostic roles of SEC14L2 in OSCC. OSCC tumors and adjacent non-tumors were collected from OSCC patients and used for SEC14L2 mRNA expression by quantitative reverse transcription PCR (RT-qPCR). Additionally, the expression of SEC14L2 was further analyzed using The Cancer Genome Atlas-Head Neck Squamous Cell Carcinoma (TCGA-HNSCC) dataset to identify its relationship with HNSCC clinical characteristics...
April 4, 2024: Odontology
https://read.qxmd.com/read/38566638/bilateral-sudden-irreversible-hearing-loss-in-a-case-of-chronic-myeloid-leukaemia-a-case-report
#13
JOURNAL ARTICLE
Hafiz Malhan, Enas Dammag, Waiel Alkahiry, Gadallah Ali, Fahad Bahkali, Anas Alhakim, Mohammad Bakkar
Chronic myeloid leukemia is a type of blood cancer that affects the bone marrow and results in an overproduction of immature WBCs. The genetic mutation that causes CML is the BCR-ABL fusion gene. Adolescents are rarely affected. The case study aims to discuss a rare case of chronic myeloid leukemia causing bilateral hearing impairment, tinnitus, and vertigo. A 30-year-old female presented to the hospital in November, 2021, with sudden hearing impairment and other symptoms, leading to a CML diagnosis. Blood tests revealed hyperleukocytosis with marked neutrophilia, mild basophilia, and eosinophilia, and a BCR-ABL quantitation of 85%...
April 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38554341/biodosimetric-analysis-of-head-and-neck-cancer-patients-undergoing-radiotherapy-by-dicentric-chromosome-aberration-assay
#14
JOURNAL ARTICLE
Nayan Agarwal, Arun K Rathi, Seema Kapoor, Kishore Singh, Savita Arora, Ankur Jindal, Kumar Prabhat, Himanshi Kaushik
BACKGROUND: Biodosimetry is the quantification of absorbed radiation dose using biological material obtained from an exposed individual. Radiation can cause different types of chromosomal aberrations, including stable aberrations like translocations and unstable ones like micronuclei, dicentric chromosomes (DC), acentric, and ring forms. Dicentric chromosome assay has become the "gold standard" for cytogenetic biodosimetry due to its reproducibility, specificity (low baseline rates), and sensitivity to low doses...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38554185/tgf-%C3%AE-1-and-tgf-%C3%AE-r1-variants-are-associated-with-clinical-outcomes-in-smoking-related-head-and-neck-cancer-patients-treated-with-chemoradiation-through-modulating-microrna-mediated-regulation
#15
JOURNAL ARTICLE
Zihao Niu, Peng Sun, Mark E Zafereo, Hongliang Liu, Peng Wei, Jia Wu, Neil D Gross, Sanjay Shete, Qingyi Wei, Guibin Zheng, Andy G Sikora, George A Calin, Guojun Li
TGF-β1 and TGF-βR1 play important roles in immune and inflammatory responses. Genetic variants of TGF-β1 rs1800470 and TGF-βR1 rs334348 have emerged as potentially prognostic biomarkers for HPV-related head and neck cancer, while their prognostic effect on survival of smoking-related head and neck cancer remains unknown. This study included 1403 patients with smoking-related head and neck cancer, and all these patients were genotyped for TGF-β1 rs1800470 and TGF-βR1 rs334348...
March 30, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38540340/sp1-gene-methylation-in-head-and-neck-squamous-cell-cancer-in-hpv-negative-patients
#16
JOURNAL ARTICLE
Enar Jumaniyazova, Anna Aghajanyan, Sergey Kurevlev, Leyla Tskhovrebova, Andrey Makarov, Konstantin Gordon, Anastasiya Lokhonina, Timur Fatkhudinov
There is still much to learn about the epigenetic mechanisms controlling gene expression during carcinogenesis. When researching aberrant DNA methylation, active proliferative tumor cells from head and neck squamous cell cancer (HNSCC) can be used as a model. The aim of the study was to investigate the methylation status of CDKN1 , CDKN2A , MYC , Smad3 , SP1 , and UBC genes in tumor tissue (control-normal tissue) in 50 patients (37 men and 13 women) with HPV-negative HNSCC. Methods: Bisulfite conversion methods and methyl-sensitive analysis of high-resolution melting curves were used to quantify the methylation of genes...
February 23, 2024: Genes
https://read.qxmd.com/read/38537502/nkx2-1-gene-is-targeted-by-h19-lncrna-and-is-found-to-be-overexpressed-in-benign-nodular-goiter-tissues
#17
JOURNAL ARTICLE
Seyed-Morteza Javadirad
OBJECTIVE: Nodular goiter may increase the risk of thyroid cancer, but the genetic factors contributing to nodular goiter are not well understood. There is an overexpression of H19 lncRNA in goiter tissue and its target remains unknown. In this study, we attempted to identify a new target for H19 in the context of goiter development. METHODS: Using interaction energy calculations, the interaction between NKX2-1 mRNA and H19 lncRNA was examined. Putative microRNAs were found at the H19 lncRNA target site with the highest affinity for NKX2-1...
February 28, 2024: Brazilian Journal of Otorhinolaryngology
https://read.qxmd.com/read/38534460/-ptch1-gene-variants-mrna-expression-and-bioinformatics-insights-in-mexican-cutaneous-squamous-cell-carcinoma-patients
#18
JOURNAL ARTICLE
Marianela Zambrano-Román, Jorge R Padilla-Gutiérrez, Yeminia Valle, José Francisco Muñoz-Valle, Elizabeth Guevara-Gutiérrez, Patricia Aidé López-Olmos, Laura Cristina Sepúlveda-Loza, Luis Alberto Bautista-Herrera, Emmanuel Valdés-Alvarado
BACKGROUND: Skin cancer is one of the most frequent types of cancer, and cutaneous squamous cell carcinoma (cSCC) constitutes 20% of non-melanoma skin cancer (NMSC) cases. PTCH1 , a tumor suppressor gene involved in the Sonic hedgehog signaling pathway, plays a crucial role in neoplastic processes. METHODS: An analytical cross-sectional study, encompassing 211 cSCC patients and 290 individuals in a control group (CG), was performed. A subgroup of samples was considered for the relative expression analysis, and the results were obtained using quantitative real-time PCR (qPCR) with TaqMan® probes...
March 16, 2024: Biology
https://read.qxmd.com/read/38529116/case-report-dostarlimab-for-treatment-of-aggressive-cutaneous-squamous-cell-carcinoma
#19
Sophia Gandarillas, Horace Tang, Bahar Dasgeb
Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy with the aggressive cSCC subtype being especially worrisome due to its higher metastatic and mortality rate. An 80-year-old immunocompetent Caucasian man presented with a locally advanced and recurrent cSCC for which he underwent six Mohs surgeries, radiation therapy, and standard immunotherapy treatments. Throughout treatment, the patient's cancer continued to progress across different regions of the face. Biopsy and analysis were performed and showed that the cSCCs had a high mutational burden and oncogenes known to be present in tumors with aggressive nature...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38528913/salivary-mirnas-as-auxiliary-liquid-biopsy-biomarkers-for-diagnosis-in-patients-with-oropharyngeal-squamous-cell-carcinoma-a-systematic-review-and-meta-analysis
#20
Huy Nguyen, Taichiro Nonaka
Objective: The healthcare system needs a novel approach to improve and diagnose early oropharyngeal squamous cell carcinoma against its low survival rate. We conduct a systematic review and a comprehensive meta-analysis for the diagnostic role of blood and salivary microRNAs (miRNAs). Methods: An unbiased and thorough literature search in PubMed yielded appropriate data from qualified articles regarding different miRNA biomarkers, method of extraction, research location, and year of publication. Stata was used to calculate the sensitivity, specificity, diagnostic odds ratio, and summary receiver operating characteristic curve...
2024: Frontiers in Genetics
keyword
keyword
161386
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.